Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Hyperion Therapeutics 

601 Gateway Boulevard
Suite 200
San Francisco  California  94080  U.S.A.
Phone: 650-745-7802 or 1-888-897-4276 Fax: 650-871-7029


 Company News
Hyperion Therapeutics Announces European Medicines Agency Acceptance For Review Of Marketing Authorization Application For RAVICTI® 6/26/2014 7:38:51 AM
Hyperion Therapeutics To Present At The JMP Healthcare Conference 6/19/2014 8:32:43 AM
Hyperion Therapeutics To Present At 2014 Wells Fargo Healthcare Conference 6/13/2014 7:56:10 AM
Hyperion Therapeutics Completes Acquisition Of Andromeda Biotech 6/12/2014 7:20:13 AM
Hyperion Therapeutics Announces Health Canada Accepts RAVICTI® New Drug Submission With Priority Review 6/3/2014 9:16:56 AM
Hyperion Therapeutics To Present At Jefferies and Co. 2014 Global Healthcare Conference 5/29/2014 9:36:13 AM
Hyperion Therapeutics To Present At Bank of America (BAC) Merrill Lynch 2014 Health Care Conference 5/8/2014 10:41:52 AM
Hyperion Therapeutics Announces First Quarter 2014 Financial Results 5/7/2014 9:03:45 AM
Hyperion Therapeutics To Report First Quarter 2014 Financial Results After Market On May 6, 2014 4/30/2014 9:10:13 AM
Hyperion Therapeutics Wagers Up To $570 Million On Andromeda Biotech To Beef Up Orphan Disease Pipeline 4/24/2014 9:03:36 AM